Cargando…

The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes

Coronavirus disease 2019 is caused by SARS-CoV-2 and is more severe in the elderly, racial minorities, and those with comorbidities such as hypertension and diabetes. These pathologies are often controlled with medications involving the renin–angiotensin–aldosterone system (RAAS). RAAS is an endocri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjbar, Tara, Oza, Palak P., Kashfi, Khosrow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699619/
https://www.ncbi.nlm.nih.gov/pubmed/36430371
http://dx.doi.org/10.3390/ijms232213895
_version_ 1784839118778269696
author Ranjbar, Tara
Oza, Palak P.
Kashfi, Khosrow
author_facet Ranjbar, Tara
Oza, Palak P.
Kashfi, Khosrow
author_sort Ranjbar, Tara
collection PubMed
description Coronavirus disease 2019 is caused by SARS-CoV-2 and is more severe in the elderly, racial minorities, and those with comorbidities such as hypertension and diabetes. These pathologies are often controlled with medications involving the renin–angiotensin–aldosterone system (RAAS). RAAS is an endocrine system involved in maintaining blood pressure and blood volume through components of the system. SARS-CoV-2 enters the cells through ACE2, a membrane-bound protein related to RAAS. Therefore, the use of RAAS inhibitors could worsen the severity of COVID-19’s symptoms, especially amongst those with pre-existing comorbidities. Although a vaccine is currently available to prevent and reduce the symptom severity of COVID-19, other options, such as nitric oxide and hydrogen sulfide, may also have utility to prevent and treat this virus.
format Online
Article
Text
id pubmed-9699619
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96996192022-11-26 The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes Ranjbar, Tara Oza, Palak P. Kashfi, Khosrow Int J Mol Sci Review Coronavirus disease 2019 is caused by SARS-CoV-2 and is more severe in the elderly, racial minorities, and those with comorbidities such as hypertension and diabetes. These pathologies are often controlled with medications involving the renin–angiotensin–aldosterone system (RAAS). RAAS is an endocrine system involved in maintaining blood pressure and blood volume through components of the system. SARS-CoV-2 enters the cells through ACE2, a membrane-bound protein related to RAAS. Therefore, the use of RAAS inhibitors could worsen the severity of COVID-19’s symptoms, especially amongst those with pre-existing comorbidities. Although a vaccine is currently available to prevent and reduce the symptom severity of COVID-19, other options, such as nitric oxide and hydrogen sulfide, may also have utility to prevent and treat this virus. MDPI 2022-11-11 /pmc/articles/PMC9699619/ /pubmed/36430371 http://dx.doi.org/10.3390/ijms232213895 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ranjbar, Tara
Oza, Palak P.
Kashfi, Khosrow
The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes
title The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes
title_full The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes
title_fullStr The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes
title_full_unstemmed The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes
title_short The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes
title_sort renin–angiotensin-aldosterone system, nitric oxide, and hydrogen sulfide at the crossroads of hypertension and covid-19: racial disparities and outcomes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699619/
https://www.ncbi.nlm.nih.gov/pubmed/36430371
http://dx.doi.org/10.3390/ijms232213895
work_keys_str_mv AT ranjbartara thereninangiotensinaldosteronesystemnitricoxideandhydrogensulfideatthecrossroadsofhypertensionandcovid19racialdisparitiesandoutcomes
AT ozapalakp thereninangiotensinaldosteronesystemnitricoxideandhydrogensulfideatthecrossroadsofhypertensionandcovid19racialdisparitiesandoutcomes
AT kashfikhosrow thereninangiotensinaldosteronesystemnitricoxideandhydrogensulfideatthecrossroadsofhypertensionandcovid19racialdisparitiesandoutcomes
AT ranjbartara reninangiotensinaldosteronesystemnitricoxideandhydrogensulfideatthecrossroadsofhypertensionandcovid19racialdisparitiesandoutcomes
AT ozapalakp reninangiotensinaldosteronesystemnitricoxideandhydrogensulfideatthecrossroadsofhypertensionandcovid19racialdisparitiesandoutcomes
AT kashfikhosrow reninangiotensinaldosteronesystemnitricoxideandhydrogensulfideatthecrossroadsofhypertensionandcovid19racialdisparitiesandoutcomes